Apotex Health Corp.
APTX.TO
TSX
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 597.07M | 825.61M | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 597.07M | 825.61M | |||
| Cost of Revenue | 300.49M | 288.23M | |||
| Gross Profit | 296.58M | 537.37M | |||
| SG&A Expenses | 178.65M | 114.76M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 22.18M | 9.66M | |||
| Total Operating Expenses | 528.76M | 440.25M | |||
| Operating Income | 68.31M | 385.35M | |||
| Income Before Tax | -9.25M | 332.01M | |||
| Income Tax Expenses | 17.75M | 69.86M | |||
| Earnings from Continuing Operations | -27.00M | 262.15M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.00M | 262.15M | |||
| EBIT | 68.31M | 385.35M | |||
| EBITDA | 88.85M | 400.11M | |||
| EPS Basic | -0.13 | 1.36 | |||
| Normalized Basic EPS | 0.04 | 1.18 | |||
| EPS Diluted | -0.13 | 1.36 | |||
| Normalized Diluted EPS | 0.04 | 1.18 | |||
| Average Basic Shares Outstanding | 201.19M | 193.04M | |||
| Average Diluted Shares Outstanding | 201.19M | 193.04M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||